Search - tctmd.com

Displaying 1 - 20 of 74

Sort: Relevancy | Date

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

News Conference News EuroPCR 2025

IVL Effective in Severely Calcified Lesions, Especially in Women

Yael L. Maxwell

May 22, 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

May 16, 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

May 16, 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

May 19, 2023

AnchorMan LAAO Device Matches Up Well With the Watchman

News Conference News EuroPCR 2023

AnchorMan LAAO Device Matches Up Well With the Watchman

May 19, 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

May 18, 2023

Renal Denervation: Exploring Its Potential Beyond Hypertension

News Conference News EuroPCR 2023

Renal Denervation: Exploring Its Potential Beyond Hypertension

May 18, 2023

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

News Conference News EuroPCR 2023

Transcatheter MV Replacement vs Best Medical Therapy? Some Clues

May 17, 2023

Two New Renal Denervation Systems Look Good in Uncontrolled BP

News Conference News EuroPCR 2023

Two New Renal Denervation Systems Look Good in Uncontrolled BP

May 17, 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

News Conference News EuroPCR 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

May 17, 2023

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL

News Conference News EuroPCR 2022

Distal Radial Access Doesn’t Lower Risk of Occlusion: DISCO RADIAL

Michael O'Riordan

May 19, 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

News Conference News EuroPCR 2021

Tricuspid Trio: TRISCEND, CLASP TR, and TriBAND Studies Show Advances

May 21, 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

News Conference News EuroPCR 2021

Complete 2-Year Data From Evolut Low-Risk Trial ‘Reassuring’ for TAVI

Yael L. Maxwell

May 19, 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

May 19, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.